Company: ARVN
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001655759-25-000075
Chunk: 69

Company: ARVINAS, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 69
---
 base salary continuation under no change in control and 12 months of base salary continuation under a change in control for Mr. Saik, Dr. Teel, Dr. Berkowitz, Dr. Cacace and Dr. Taylor.

(3) Non-equity incentive plan compensation payment amount assumes no bonus amounts for 2024 have been paid to the executive as of December 31, 2024, and that all 2023 bonus amounts have been paid as of such date, in each case, as would be consistent with the company’s historical practice. Represents an amount equal to 150% of Dr. Houston’s annual target bonus for 2024. Represents an amount equal to 100% of the annual target bonus for 2024 for Mr. Saik, Dr. Teel, Dr. Berkowitz, Dr. Cacace and Dr. Taylor.

(4) With respect to Options, reflects the in-the-money value of the unvested portion of such named executive officer’s options. The value is calculated by multiplying the amount (if any) by which $19.17, the closing price of our common stock on The Nasdaq Global Select Market on December 31, 2024, exceeds the exercise price of the Option by the number of shares subject to the accelerated portion of the Option. With respect to RSUs and restricted stock, the value is calculated by multiplying the number of unvested RSUs and restricted stock with vesting provisions based solely on time by $19.17, the closing price of our common stock on The Nasdaq Global Select Market on December 31, 2024.

(5) Represents 12 months and 18 months of reimbursement of a portion of Dr. Houston’s and dependents’ health and dental COBRA premiums to the same extent as if the executive remained employed for no change in control and change in control respectively. Represents nine months and 12 months of reimbursement of a portion of Mr. Saik’s and Dr. Teel’s and dependents’ health and dental COBRA premiums to the same extent as if the executive remained employed for no change in control and change in control respectively. Dr. Berkowitz, Dr. Cacace and Dr. Taylor do not participate in our health and dental plans and therefore are not currently entitled to any COBRA premiums.

#### Compensation Committee Report
The compensation committee has reviewed and discussed the disclosure included in the Compensation Discussion and Analysis section of this Proxy Statement with management. Based on this review and discussion,